Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Orphazyme A/S ADR (NQ: ORPH )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Orphazyme A/S ADR

< Previous 1 2 3 4 5 6 7 Next >
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Orphazyme A/S (ORPH) on Behalf of Investors
From Glancy Prongay & Murray LLP
Via Business Wire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Orphazyme A/S (ORPH) on Behalf of Investors
From Law Offices of Howard G. Smith
Via Business Wire
SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Orphazyme A/S and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
From The Schall Law Firm
Via Business Wire
EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Orphazyme A/S Investors with Losses to Secure Counsel Before Important Deadline – ORPH
From The Rosen Law Firm, P.A.
Via Business Wire
ORPHAZYME ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Orphazyme A/S and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
ORPHAZYME INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Orpahzyme A/S Class Action Lawsuit - ORPH
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Orphazyme’s Massive Price Appreciation Won’t Be Captured Again
ORPH stock multiplied overnight to lofty highs, but it clearly won't happen again due to its very small market capitalization. 
Via InvestorPlace
Orphazyme A/S May Look Like a Long Shot, but Things Aren’t That Dire
The odds of positive subsequent news, and a short squeeze, could outweigh the risk dilution and more disappointment sends ORPH stock lower. 
Via InvestorPlace
Attention Biotech Investors: Mark Your Calendar For July PDUFA Dates
June was a month of plenty and also turned out to be a fruitful one from the perspective of Food and Drug Administration approvals. Regulatory reviews mostly produced positive... 
Via Benzinga
Despite FDA Disappointment, All Hope Isn’t Lost for Orphazyme
Resilient ORPH stock bulls managed to hold their ground even amid a regulatory setback. Could a major rally be just around the corner? 
Via InvestorPlace
Exposures Product Safety
ORPH Stock: The Big News That Has Red-Hot Orphazyme Gaining Today
Two key announcements from Orphazyme are sending shares of ORPH stock higher today, as investors continue to reprice this biopharma stock. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock moved upwards by 93.55% to $24.33 during Tuesday's regular session. As of 12:30 EST, this security is trading at... 
Via Benzinga
Orphazyme To Cut Two-Third Workforce Under Restructuring; Reaffirms FY21 Outlook
Orphazyme A/S (NASDAQ: ORPH) plans an approximate two-thirds reduction in its global workforce due to a restructuring, aiming to advance its corporate strategy and... 
Via Benzinga
45 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares surged 105.3% to close at $3.51 on Thursday after the company announced it has added the ability to manage Instacart Ads... 
Via Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) jumped 58% to $2.70 after the company announced it has added the ability to manage Instacart Ads to its flagship MarinOne... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Aravive (NASDAQ:ARAV) stock moved upwards by 21.61% to $6.47 during Thursday's pre-market session. The company's market cap stands at $131.9 million. Arcus... 
Via Benzinga
25 Stocks Moving in Thursday's Pre-Market Session
Gainers Marin Software Incorporated (NASDAQ: MRIN) rose 43.3% to $2.45 in pre-market trading after the company announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
45 Biggest Movers From Yesterday
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613. First... 
Via Benzinga
Why Orphazyme Stock Skyrocketed 24.6% Today
Goldman Sachs upped its stake in the drugmaker -- but only briefly. 
Via The Motley Fool
ORPH Stock: Why Orphazyme Is Gaining Today Despite FDA Disappointment
Today's massive upward move in ORPH stock appears to be the result of a disclosed stake in the company of more than 5% from Goldman Sachs. 
Via InvestorPlace
Exposures Product Safety
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today
Entera Bio Ltd. (NASDAQ: ENTX), Orphazyme A/S (NASDAQ: ORPH) and Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) are among the biggest biopharma movers Wednesday. Entera Bio Climbs... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 32.66% to $7.92 during Wednesday's regular session. As of 12:30 EST, this security is trading at a volume of... 
Via Benzinga
Former Wall Street Floor Trader: Tesla Is Going To $700
Longtime trader David Green thinks Tesla Inc (NASDAQ:TSLA)... 
Via Benzinga
31 Stocks Moving In Wednesday's Mid-Day Session
Gainers Entera Bio Ltd. (NASDAQ: ENTX) shares jumped 58% to $7.09 after the company reported topline Phase 2 bone mineral density data for EB613. Orphazyme A/S (NASDAQ: ORPH)... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers vTv Therapeutics (NASDAQ:VTVT) shares rose 30.08% to $3.07 during Tuesday's pre-market session. The company's market cap stands at $251.7 million. Adial... 
Via Benzinga
48 Biggest Movers From Yesterday
Gainers Lydall, Inc. (NYSE: LDL) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share. New Concept Energy,... 
Via Benzinga
Assess Biotech Landscape Hazards Before Trading Orphazyme Stock
While I won’t bother making a strong bull nor bear case for ORPH stock, you do need to perform your due diligence before placing a bet. 
Via InvestorPlace
31 Stocks Moving In Monday's Mid-Day Session
Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)... 
Via Benzinga
21 Stocks Moving in Monday's Pre-Market Session
Gainers Raven Industries, Inc. (NASDAQ: RAVN) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V (NYSE: CNHI) announced plans to acquire Raven Industries for $58 per... 
Via Benzinga
58 Biggest Movers From Friday
Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc.... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.